MedPath

Clinical Study on the immune Enhancing Effect of Nidigdhikadi Leha on Upper Respiratory Tract Infections (URTI)

Phase 2
Conditions
Health Condition 1: J399- Disease of upper respiratory tract, unspecified
Registration Number
CTRI/2020/08/027386
Lead Sponsor
ational Institute of Ayurveda Jaipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Children aged between 6 to 12 years of either sex.

2) Children with recurrent upper respiratory infections.

3) Children whose parents are willing to give consent for clinical trail.

Exclusion Criteria

1) Children suffering from major systemic

illness necessitating hospitalization.

2) Children with evidence of malignancy,

genetic or congenital anomaly.

3) Children with concurrent serious hepatic

dysfunction (defined as AST and/or

ALT >3 times of the upper normal limit)

or renal dysfunction (defined as S.

creatinine >1.2mg/dl) uncontrolled

pulmonary dysfunction (asthmatic and

COPD patients)

4) Chronic illness like TB, UTI and bleeding

disorders etc.

5) H/o hypersensitivity to any of the trial

drug or their ingredients.

6) Children who have completed

participation in any other clinical trial

during the past six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath